JP2022549086A5 - - Google Patents

Info

Publication number
JP2022549086A5
JP2022549086A5 JP2022516299A JP2022516299A JP2022549086A5 JP 2022549086 A5 JP2022549086 A5 JP 2022549086A5 JP 2022516299 A JP2022516299 A JP 2022516299A JP 2022516299 A JP2022516299 A JP 2022516299A JP 2022549086 A5 JP2022549086 A5 JP 2022549086A5
Authority
JP
Japan
Prior art keywords
methyl
imidazole
urea
phenyl
thienylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516299A
Other languages
English (en)
Japanese (ja)
Other versions
JP7771049B2 (ja
JP2022549086A (ja
Filing date
Publication date
Priority claimed from GB201913603A external-priority patent/GB201913603D0/en
Application filed filed Critical
Publication of JP2022549086A publication Critical patent/JP2022549086A/ja
Publication of JP2022549086A5 publication Critical patent/JP2022549086A5/ja
Priority to JP2025186669A priority Critical patent/JP2026041728A/ja
Application granted granted Critical
Publication of JP7771049B2 publication Critical patent/JP7771049B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516299A 2019-09-20 2020-09-18 新化合物 Active JP7771049B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025186669A JP2026041728A (ja) 2019-09-20 2025-11-05 新化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201913603A GB201913603D0 (en) 2019-09-20 2019-09-20 New compounds
GB1913603.5 2019-09-20
PCT/GB2020/052261 WO2021053344A1 (en) 2019-09-20 2020-09-18 New compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025186669A Division JP2026041728A (ja) 2019-09-20 2025-11-05 新化合物

Publications (3)

Publication Number Publication Date
JP2022549086A JP2022549086A (ja) 2022-11-24
JP2022549086A5 true JP2022549086A5 (cg-RX-API-DMAC7.html) 2023-09-06
JP7771049B2 JP7771049B2 (ja) 2025-11-17

Family

ID=68425648

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022516299A Active JP7771049B2 (ja) 2019-09-20 2020-09-18 新化合物
JP2025186669A Pending JP2026041728A (ja) 2019-09-20 2025-11-05 新化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025186669A Pending JP2026041728A (ja) 2019-09-20 2025-11-05 新化合物

Country Status (15)

Country Link
US (2) US12435072B2 (cg-RX-API-DMAC7.html)
EP (1) EP4031240A1 (cg-RX-API-DMAC7.html)
JP (2) JP7771049B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220101071A (cg-RX-API-DMAC7.html)
CN (1) CN114786774A (cg-RX-API-DMAC7.html)
AU (2) AU2020351301C1 (cg-RX-API-DMAC7.html)
BR (1) BR112022003130A2 (cg-RX-API-DMAC7.html)
CA (1) CA3152218A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022000656A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022003091A2 (cg-RX-API-DMAC7.html)
GB (1) GB201913603D0 (cg-RX-API-DMAC7.html)
IL (1) IL291172A (cg-RX-API-DMAC7.html)
MX (2) MX2022003286A (cg-RX-API-DMAC7.html)
PH (1) PH12022550564A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021053344A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004094D0 (en) * 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202013721D0 (en) * 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
JP2024511453A (ja) * 2021-03-23 2024-03-13 ヴィコール ファルマ アーベー 選択的アンジオテンシンii受容体リガンド
GB202113583D0 (en) * 2021-09-23 2021-11-10 Vicore Pharma Ab New compounds
GB202104033D0 (en) * 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB2605148A (en) * 2021-03-23 2022-09-28 Vicore Pharma Ab New compounds
GB202104038D0 (en) * 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
CA3222721A1 (en) * 2021-07-09 2023-01-12 Nadia Nasser PETERSEN New selective angiotensin ii compounds
WO2023193733A1 (zh) * 2022-04-06 2023-10-12 武汉人福创新药物研发中心有限公司 一种at2r激动剂
WO2024133942A1 (en) 2022-12-22 2024-06-27 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
CN120569378A (zh) * 2023-01-09 2025-08-29 维科尔药物公司 选择性血管紧张素ii化合物
CN119504723A (zh) * 2023-08-25 2025-02-25 武汉人福创新药物研发中心有限公司 作为at2r激动剂的噻吩磺酰基氨基甲酸酯
WO2025146172A1 (zh) * 2024-01-03 2025-07-10 武汉人福创新药物研发中心有限公司 一种并环类化合物作为at2r激动剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5312820A (en) 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
SE9800550D0 (sv) 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
DE19920815A1 (de) 1999-05-05 2000-11-09 Aventis Pharma Gmbh 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
YU78601A (sh) * 1999-05-05 2005-07-19 Aventis Pharma Deutschland Gmbh. 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
JP4707321B2 (ja) 2001-05-31 2011-06-22 ヴィコール・ファルマ・アーベー アンギオテンシンiiアゴニストとして有用な三環式化合物
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
AU2003302106A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New tricyclic angiotensin ii agonists
AU2006235698B2 (en) 2005-04-12 2012-03-29 Vicore Pharma Ab New tricyclic angiotensin II agonists
US8835471B2 (en) * 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
JP2015504870A (ja) * 2011-12-16 2015-02-16 タリックス ファーマシューティカルズ リミテッド 線維症を処置するためのアンジオテンシン
ES2834430T3 (es) 2013-03-15 2021-06-17 Univ Southern California Procedimientos, compuestos y composiciones para el tratamiento de enfermedades relacionadas con la angiotensina
EP2832357A1 (en) 2013-07-29 2015-02-04 Charité - Universitätsmedizin Berlin Selective AT2 receptor agonists for use in treatment of cachexia
US20170266164A1 (en) 2014-12-12 2017-09-21 Vicore Pharma Ab New methods and uses
WO2016107879A2 (en) 2014-12-30 2016-07-07 Vicore Pharma Ab New use of angiotensin ii receptor agonists
HK1244232A1 (zh) 2015-03-02 2018-08-03 维科尔药物公司 用於治疗肺纤维化的血管紧张素ii受体激动剂
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
BR112018077075A2 (pt) 2016-06-29 2019-04-30 Universite De Montreal heterociclos de biarilmetila
GB201710906D0 (en) 2017-07-06 2017-08-23 Vicore Pharma Ab Compounds and methods for treating peripheral neuropathy

Similar Documents

Publication Publication Date Title
JP2018535999A5 (cg-RX-API-DMAC7.html)
JP2022191517A5 (cg-RX-API-DMAC7.html)
JP2021535104A5 (cg-RX-API-DMAC7.html)
JP2023539614A5 (cg-RX-API-DMAC7.html)
JP2019518036A5 (cg-RX-API-DMAC7.html)
JP2014511869A5 (cg-RX-API-DMAC7.html)
JP2004524301A5 (cg-RX-API-DMAC7.html)
JP2008513500A5 (cg-RX-API-DMAC7.html)
JP2010504280A5 (cg-RX-API-DMAC7.html)
JP2020516671A5 (cg-RX-API-DMAC7.html)
JP2009525340A5 (cg-RX-API-DMAC7.html)
JP2013531070A5 (cg-RX-API-DMAC7.html)
JP2007517010A5 (cg-RX-API-DMAC7.html)
JP2007508346A5 (cg-RX-API-DMAC7.html)
JP2023518948A5 (cg-RX-API-DMAC7.html)
JP2005538955A5 (cg-RX-API-DMAC7.html)
JP2005511543A5 (cg-RX-API-DMAC7.html)
JP2004511469A5 (cg-RX-API-DMAC7.html)
RU2008141509A (ru) Mglur5 модуляторы 1
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
JP2007511485A5 (cg-RX-API-DMAC7.html)
JP2007519695A5 (cg-RX-API-DMAC7.html)
JP2006506380A5 (cg-RX-API-DMAC7.html)
JP2020500192A5 (cg-RX-API-DMAC7.html)
JP2021535134A5 (cg-RX-API-DMAC7.html)